Orientations
Pneumococcal Vaccine: Handling the change in product manufacturer and presentation
Summary guidance for national authorities and immunization programme managers for the switch from GlaxoSmithKline Biologicals SA Synflorix® (PCV 10) to Pfizer Prevenar13® vaccine (PCV 13)
Auteurs
Langues
- Portuguais
Année de publication
2017
Type
Catégories
Maladies
Organisations